Sign In
Buy OGN
$13.40
+0.0200 (+0.149%)
At Close: Jun 03, 2026
Four Reasons Why Organon Stock Is A Good Buy
12:43pm, Tuesday, 07'th May 2024
OGN has underperformed its healthcare peers and the benchmark over the past year, but this could change going forward. The company's dominant women's health product- Nexplanon is looking at double-dig
Organon Announces Proposed $1.0 Billion Senior Notes Offering
07:58am, Tuesday, 07'th May 2024
JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon (NYSE: OGN) (“Organon”), a global healthcare company with a focus on women's health, announced today that it, together with Organon Foreign Debt Co-Issu
What Makes Organon (OGN) a New Buy Stock
01:01pm, Thursday, 02'nd May 2024
Organon (OGN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Organon & Co. (OGN) Q1 2024 Earnings Call Transcript
11:09am, Thursday, 02'nd May 2024
Organon & Co. (NYSE:OGN ) Q1 2024 Earnings Conference Call May 2, 2024 8:30 AM ET Company Participants Jennifer Halchak - Vice President, Investor Relations Kevin Ali - Chief Executive Officer Matt Wa
Organon (OGN) Tops Q1 Earnings and Revenue Estimates
09:55am, Thursday, 02'nd May 2024
Organon (OGN) came out with quarterly earnings of $1.22 per share, beating the Zacks Consensus Estimate of $0.97 per share. This compares to earnings of $1.08 per share a year ago.
Organon Reports Results for the First Quarter Ended March 31, 2024
07:30am, Thursday, 02'nd May 2024
JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon Reports Results for the First Quarter Ended March 31, 2024.
7 Sleeper Stocks to Buy Before Wall Street Wakes Up: April 2024
01:26pm, Wednesday, 01'st May 2024
Sleeper stocks to buy – based on Nasdaq.com's glossary – represent securities that offer significant price appreciation potential once its fundamentals have been recognized. That could cover a lot
Organon (OGN) Gears Up to Report Q1 Earnings: What's in Store?
12:05pm, Wednesday, 01'st May 2024
Organon's (OGN) first-quarter results are likely to reflect growth in its biosimilars and established brand franchises with lighter fertility product sales amid foreign exchange headwinds.
3 Healthcare Stocks With the Potential to Triple Your Investment by 2026
10:47am, Wednesday, 01'st May 2024
Finding firms with strong growth potential is essential for healthcare investors looking for large profits. Three exceptional firms have surfaced as strong healthcare stocks.
Stay Ahead of the Game With Organon (OGN) Q1 Earnings: Wall Street's Insights on Key Metrics
10:22am, Monday, 29'th Apr 2024
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Organon (OGN), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the qua
Earnings Preview: Organon (OGN) Q1 Earnings Expected to Decline
11:08am, Thursday, 25'th Apr 2024
Organon (OGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Organon (OGN) Surpasses Market Returns: Some Facts Worth Knowing
07:05pm, Wednesday, 24'th Apr 2024
Organon (OGN) reachead $18.71 at the closing of the latest trading day, reflecting a +1.03% change compared to its last close.
Organon (OGN) Beats Stock Market Upswing: What Investors Need to Know
07:21pm, Monday, 22'nd Apr 2024
In the closing of the recent trading day, Organon (OGN) stood at $18, denoting a +1.01% change from the preceding trading day.
Organon (OGN) Advances While Market Declines: Some Information for Investors
07:21pm, Monday, 15'th Apr 2024
In the latest trading session, Organon (OGN) closed at $17.71, marking a +1.49% move from the previous day.
Play Safe! S&P 500 is Teasingly Close to its 50 DMA: 3 Picks
09:11am, Friday, 12'th Apr 2024
With the S&P 500 trading close to its 50-day moving average, it's wise for investors to place bets on safe stocks such as Iron Mountain (IRM), Organon (OGN), and International Business Machines (IBM).
